Therefore, this review aims to provide a thorough overview of the latest research on METTL16 in cancer development and tumor immune regulation, elucidate its potential molecular mechanisms and clinical implications, and highlight the prospective value of METTL16 as a diagnostic biomarker or immunotherapeutic target, offering a theoretical foundation for future basic and translational studies. Here, METTL16 is linked to neoplasm.